rs137852459
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000132.4(F8):āc.6371A>Gā(p.Tyr2124Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000183 in 1,095,316 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Genomes: not found (cov: 22)
Exomes š: 0.0000018 ( 0 hom. 1 hem. )
Consequence
F8
NM_000132.4 missense
NM_000132.4 missense
Scores
10
6
1
Clinical Significance
Conservation
PhyloP100: 6.96
Genes affected
F8 (HGNC:3546): (coagulation factor VIII) This gene encodes coagulation factor VIII, which participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 and phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma and associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PM1
In a disulfide_bond (size 148) in uniprot entity FA8_HUMAN there are 32 pathogenic changes around while only 0 benign (100%) in NM_000132.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.991
PP5
Variant X-154896135-T-C is Pathogenic according to our data. Variant chrX-154896135-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 10310.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154896135-T-C is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
F8 | NM_000132.4 | c.6371A>G | p.Tyr2124Cys | missense_variant | 22/26 | ENST00000360256.9 | NP_000123.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F8 | ENST00000360256.9 | c.6371A>G | p.Tyr2124Cys | missense_variant | 22/26 | 1 | NM_000132.4 | ENSP00000353393.4 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
GnomAD3 exomes AF: 0.00000546 AC: 1AN: 183296Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67736
GnomAD3 exomes
AF:
AC:
1
AN:
183296
Hom.:
AF XY:
AC XY:
1
AN XY:
67736
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000183 AC: 2AN: 1095316Hom.: 0 Cov.: 30 AF XY: 0.00000277 AC XY: 1AN XY: 360772
GnomAD4 exome
AF:
AC:
2
AN:
1095316
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
360772
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary factor VIII deficiency disease Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 03, 2024 | Variant summary: F8 c.6371A>G (p.Tyr2124Cys) results in a non-conservative amino acid change located in the Coagulation factor 5/8 C-terminal domain (IPR000421) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.5e-06 in 183296 control chromosomes. c.6371A>G has been reported in the literature in multiple individuals affected with milder/non-severe Factor VIII Deficiency (Hemophilia A). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 23926300, 22103590). ClinVar contains an entry for this variant (Variation ID: 10310). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 1993 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | May 03, 2021 | The F8 6371A>G; p.Tyr2124Cys variant (rs137852459), also known as Tyr2105Cys, has been described in the literature in numerous individuals with mild/moderate hemophilia A (Naylor 1993, Margaglione 2008, Johnsen 2017, Williams 2015, F8 database), and it is also reported in ClinVar (Variation ID: 10310). This variant is only observed on one allele (one hemizygote) in the Genome Aggregation Database, indicating it is not a common polymorphism. The tyrosine at codon 2124 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.97). Taken together, this variant is considered pathogenic. References: Naylor JA et al. Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patients. Hum Mol Genet. 1993 Jan;2(1):11-7. PMID: 8490618 Margaglione M et al. The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype. Haematologica. 2008 May;93(5):722-8. PMID: 18387975 Johnsen JM et al. Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative. Blood Adv. 2017 May 18;1(13):824-834. PMID: 29296726 Williams VK et al. Extensive bleeding due to an inhibitor in a haemophilia A patient with a Tyr2105Cys mutation: elimination of the inhibitor with rituximab. Pathology. 2015 Oct;47(6):586-8. PMID: 26308136 Link to F8 database: https://f8-db.eahad.org/VariantPage.php?ID=1594&hash=2a3f84a96bdd139de9f11adfe4865fbc - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Feb 10, 2023 | The F8 c.6371A>G variant is classified as Likely Pathogenic (PS4_Moderate, PM1, PM2, PP3) The F8 c.6371A>G variant is a single nucleotide change in exon 22/26 of the F8 gene, which is predicted to change the amino acid tyrosine at position 2124 in the protein to cysteine. The variant has been reported in numerous individuals with a clinical presentation of mild to severe haemophilia as reported in the EAHAD F8 Variant database (PS4_Mod). Note that this variant is also reported in the literature as Tyr2105Cys.This variant is absent from population databases (PM2). This variant is located in the Factor VIII C domain which contains key binding sites for von Willebrand factor (vWF) and phospholipid membranes (PMID: 10910913) (PM1). Computational predictions support a deleterious effect on the gene or gene product (PP3). The variant has been reported in dbSNP (rs137852459) and in the HGMD database: CM930235. It has been reported as Likely pathogenic by other diagnostic laboratories (ClinVar Variation ID: 10310). - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 23, 2020 | PP3, PM2, PS4_moderate, PP1_strong - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of ubiquitination at K2129 (P = 0.1295);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at